Literature DB >> 16134942

Conformationally constrained analogues of diacylglycerol (DAG). 25. Exploration of the sn-1 and sn-2 carbonyl functionality reveals the essential role of the sn-1 carbonyl at the lipid interface in the binding of DAG-lactones to protein kinase C.

Ji-Hye Kang1, Megan L Peach, Yongmei Pu, Nancy E Lewin, Marc C Nicklaus, Peter M Blumberg, Victor E Marquez.   

Abstract

Diacylglycerol (DAG) lactones with altered functionality (C=O --> CH(2) or C=O --> C=S) at the sn-1 and sn-2 carbonyl pharmacophores were synthesized and used as probes to dissect the individual role of each carbonyl in the binding to protein kinase C (PKC). The results suggest that the hydrated sn-1 carbonyl is engaged in very strong hydrogen-bonding interactions with the charged lipid headgroups and organized water molecules at the lipid interface. Conversely, the sn-2 carbonyl has a more modest contribution to the binding process as a result of its involvement with the receptor (C1 domain) via conventional hydrogen bonding to the protein. The parent DAG-lactones, E-6 and Z-7, were designed to bind exclusively in the sn-2 binding mode to ensure the correct orientation and disposition of pharmacophores at the binding site.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16134942      PMCID: PMC2563800          DOI: 10.1021/jm050352m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  27 in total

1.  Role of hydrophobic residues in the C1b domain of protein kinase C delta on ligand and phospholipid interactions.

Authors:  Q J Wang; T W Fang; K Nacro; V E Marquez; S Wang; P M Blumberg
Journal:  J Biol Chem       Date:  2001-03-14       Impact factor: 5.157

Review 2.  Regulation of protein kinase C.

Authors:  A C Newton
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

3.  A mechanism for the partial insertion of protein kinase C into membranes.

Authors:  M Yin; R S Ochs
Journal:  Biochem Biophys Res Commun       Date:  2001-03       Impact factor: 3.575

4.  Conformationally constrained analogues of diacylglycerol. 18. The incorporation of a hydroxamate moiety into diacylglycerol-lactones reduces lipophilicity and helps discriminate between sn-1 and sn-2 binding modes to protein kinase C (PK-C). Implications for isozyme specificity.

Authors:  J Lee; K C Han; J H Kang; L L Pearce; N E Lewin; S Yan; S Benzaria; M C Nicklaus; P M Blumberg; V E Marquez
Journal:  J Med Chem       Date:  2001-12-06       Impact factor: 7.446

5.  Molecular interaction model for the C1B domain of protein kinase C-gamma in the complex with its activator phorbol-12-myristate-13-acetate in water solution and lipid bilayer.

Authors:  Jozef Hritz; Jozef Ulicny; Aatto Laaksonen; Daniel Jancura; Pavol Miskovsky
Journal:  J Med Chem       Date:  2004-12-16       Impact factor: 7.446

6.  Protein kinase C ligands based on tetrahydrofuran templates containing a new set of phorbol ester pharmacophores.

Authors:  J Lee; J H Kang; S Y Lee; K C Han; C M Torres; D K Bhattacharyya; P M Blumberg; V E Marquez
Journal:  J Med Chem       Date:  1999-10-07       Impact factor: 7.446

Review 7.  Diacylglycerol's affair with protein kinase C turns 25.

Authors:  Alexandra C Newton
Journal:  Trends Pharmacol Sci       Date:  2004-04       Impact factor: 14.819

8.  Differential binding modes of diacylglycerol (DAG) and DAG lactones to protein kinase C (PK-C).

Authors:  Dina M Sigano; Megan L Peach; Kassoum Nacro; Yongseok Choi; Nancy E Lewin; Marc C Nicklaus; Peter M Blumberg; Victor E Marquez
Journal:  J Med Chem       Date:  2003-04-24       Impact factor: 7.446

9.  Low affinity binding of phorbol esters to protein kinase C and its recombinant cysteine-rich region in the absence of phospholipids.

Authors:  M G Kazanietz; J J Barchi; J G Omichinski; P M Blumberg
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

10.  Direct visualization of the translocation of the gamma-subspecies of protein kinase C in living cells using fusion proteins with green fluorescent protein.

Authors:  N Sakai; K Sasaki; N Ikegaki; Y Shirai; Y Ono; N Saito
Journal:  J Cell Biol       Date:  1997-12-15       Impact factor: 10.539

View more
  7 in total

1.  Design and synthesis of protein kinase C epsilon selective diacylglycerol lactones (DAG-lactones).

Authors:  Jihyae Ann; Suyoung Yoon; Jisoo Baek; Da Hye Kim; Nancy E Lewin; Colin S Hill; Peter M Blumberg; Jeewoo Lee
Journal:  Eur J Med Chem       Date:  2014-11-13       Impact factor: 6.514

2.  The C1 domain of Vav3, a novel potential therapeutic target.

Authors:  Jessica S Kelsey; Tamás Géczy; Christopher J Kaler; Peter M Blumberg
Journal:  Cell Signal       Date:  2017-09-18       Impact factor: 4.315

3.  Synthesis, biological, and biophysical studies of DAG-indololactones designed as selective activators of RasGRP.

Authors:  Lia C Garcia; Lucia Gandolfi Donadío; Ella Mann; Sofiya Kolusheva; Noemi Kedei; Nancy E Lewin; Colin S Hill; Jessica S Kelsey; Jing Yang; Timothy E Esch; Marina Santos; Megan L Peach; James A Kelley; Peter M Blumberg; Raz Jelinek; Victor E Marquez; Maria J Comin
Journal:  Bioorg Med Chem       Date:  2014-04-20       Impact factor: 3.641

4.  Protein kinase C regulates mitochondrial targeting of Nur77 and its family member Nor-1 in thymocytes undergoing apoptosis.

Authors:  Jennifer Thompson; Megan L Burger; Hannah Whang; Astar Winoto
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

Review 5.  Wealth of opportunity - the C1 domain as a target for drug development.

Authors:  P M Blumberg; N Kedei; N E Lewin; D Yang; G Czifra; Y Pu; M L Peach; V E Marquez
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

Review 6.  Structural insights into C1-ligand interactions: Filling the gaps by in silico methods.

Authors:  Sachin Katti; Tatyana I Igumenova
Journal:  Adv Biol Regul       Date:  2021-01-18

7.  Combining docking with pharmacophore filtering for improved virtual screening.

Authors:  Megan L Peach; Marc C Nicklaus
Journal:  J Cheminform       Date:  2009-05-20       Impact factor: 5.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.